Skip to main content
Erschienen in: BMC Cancer 1/2006

Open Access 01.12.2006 | Case report

Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report

verfasst von: Daniela Cabibi, Anna Martorana, Francesco Cappello, Elisa Barresi, Claudio Di Gangi, Vito Rodolico

Erschienen in: BMC Cancer | Ausgabe 1/2006

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Transformation of a cystic benign teratoma of the ovary into a "carcinosarcoma" has very rarely been reported and its histogenetic origin is still debated.

Case presentation

A case of carcinosarcoma arising from a dermoid cyst is reported. The tumor showed cystic areas delimited by normal squamous epithelium, with transitional areas through dysplastic epithelium to "in situ" and infiltrating squamous cell carcinoma (SCC).
The sarcomatous component showed compact tissue composed of round cells concentrically arranged around small vessels, spindle, and pleomorphic cells with a high nuclear-cytoplasmic ratio.
Positive staining for vimentin, alpha smooth muscle actin and CD10, as well as P53 and P63, was found in the sarcomatous component and in some atypical basal cells of the squamous epithelium, which also showed the usual epithelial markers.

Conclusion

To the best of our knowledge, this is the first case of carcinosarcoma arising from a dermoid cyst in which a histogenetic origin from totipotent stem cells, located in the basal squamous layer, is supported by immunohistochemical findings.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1471-2407-6-47) contains supplementary material, which is available to authorized users.

Competing interest

The author(s) declare that they have not competing interests.

Authors' contributions

DC designed the study and drafted the manuscript.
AM collected the specimens and carried out the immunohistochemistry.
FC participated in the draft of the manuscript.
EB participated in the examination of the immunohistochemistry.
CDG participated in the collection of specimens.
VR participated in the design of the study and in the draft of the manuscript

Background

A dermoid cyst or benign cystic teratoma is one of the most common tumors in women during reproductive life. Malignant transformation within a dermoid cyst is an infrequent occurrence estimated at less than 2% [1]. The most frequent malignant transformations are squamous cell carcinoma (SCC), adenocarcinoma and pure sarcoma. A carcinosarcoma arising in a dermoid cyst is a very rare event, being considered unlikely until a few years ago [2, 3]. To date, only three isolated cases have been reported [46]. However, two of these were described as a "collision tumor" [5] or "double malignancy" [6], since these tumors showed a well demarcated boundary between the squamous and sarcomatous areas [5], or consisted of a leiomyosarcoma associated with an "in situ squamous cell carcinoma" [6]. In 1996, Arora and Haldane described a neoplasia arising from a dermoid cyst in the ovary, comprising both adenocarcinomatous and fibrosarcomatous areas, and underlined the need to distinguish their case from malignant mixed Mullerian tumours (MMMTs) that have "carcinomatous and sarcomatous components, but are generally solid and lack the characteristic squamous epithelial lined cyst" [4]. We report here a case of carcinosarcoma characterized by the presence of a "squamous epithelial lined cyst" with transitional areas from benign through premalignant to malignant squamous epithelium.
The most widely accepted hypothesis about the histogenesis of carcinosarcoma is that it originates from stem cells, which are present in almost all tissues and may generate different cellular lineages by the multi-step process named "differentiation". The role of stem cells in tumorigenesis has been clearly demonstrated in a number of carcinogenic models [79].
In the past, the histogenetic explanation of carcinosarcoma was based on the "multiclonal hypothesis", which proposed an origin from two or more stem cells of distinct mesenchymal and epithelial origins. Recent studies, showing clonal identity among various foci of carcinosarcomas, have supported a "monoclonal hypothesis", which proposes an origin from a single totipotential stem cell that differentiates along distinct epithelial and mesenchymal pathways [10]. Concordance of positive p53 staining in both the epithelial and sarcomatous components of carcinosarcomas has been adduced in support of the monoclonal hypothesis [11].
In this report, we hypothesize that this rare neoplasia originates from totipotent stem cells, located in the basal squamous layer of the dermoid cyst, and we present immunohistochemical evidence of aberrant expression of mesenchymal markers (vimentin and alpha smooth muscle actin), together with positive staining for CD10, P53 and P63, in some atypical basal squamous cells.

Case presentation

A 69 year-old woman, with abdominal pain, showed a large pelvic mass. She had undergone a colpohysterectomy for uterine descensus without ovariectomy three years earlier. Ultrasound showed an ovarian mass with both solid and cystic areas. The patient underwent a bilateral salpingo-oophorectomy.
The right ovary, surgically resected, was greatly enlarged (27 × 12, 5 × 4 cm). Sections showed cystic areas containing soft yellow material and hairs, as well as solid areas with hemorrhage and necrosis. In contrast, the left ovary appeared normal. Formalin-fixed paraffin-embedded tissues were stained with hematoxilin-eosin and Periodic acid-Schiff reagent. Immunohistochemical studies were performed using the streptavidin-biotin peroxidase method. The antibodies used were against cytokeratins (AE1/AE3, CAM 5.2, MNF 116) (Dako, Denmark), EMA, vimentin, alpha smooth muscle actin, estrogen and progesterone receptors, p53, p63 (all from Biogenex-Menarini, Netherland), CD10 and desmin (both from Diapath-Novocastra, Newcastle, United Kingdom). For each antibody, appropriate positive and negative controls were included.

Histological findings

The tumor had features of a carcinosarcoma with cystic areas delimited by squamous epithelium, focally without atypias (Figure 1a) but with transitional areas from benign through premalignant to "in situ" and infiltrating carcinoma. Hair follicle buds were sometimes present in proximity to the squamous components.
The sarcomatous component showed compact tissue composed of round cells arranged concentrically around small vessels, spindle, and pleomorphic cells with a high nuclear-cytoplasmic ratio (Figure 1b). Necrosis and hemorrhage were abundant. Interestingly, islands of SCC were distributed among sarcomatous areas, without a well-demarcated boundary.

Immunohistochemical findings

The squamous component stained positively for EMA and cytokeratins AE1/AE3 (Figure 1c) and, MNF 116. In contrast, the stromal component was positive for vimentin, CD10 and, focally, for alpha smooth muscle actin.
Moreover, vimentin, alpha smooth muscle actin and CD10 were positive in atypical basal cells of the squamous epithelium infiltrating both lining cystic areas (Figures 1d–e–f).
Desmin was expressed in fewer than 5% of the stromal cells.
Estrogen receptors were negative. Progesterone receptors were positive in 10% of the sarcomatous cells. P53 and P63 showed positive nuclears staining in about 20% of the tumor cells, in both the sarcomatous and the squamous areas, and in the atypical basal cells of the squamous lining.

Conclusion

This report describes a case of a partly cystic tumour that showed the "characteristic squamous epithelial lined cyst" described by Arora and Haldane [4]. The epithelial and stromal components were closely intermixed without well-demarcated boundaries, and there were "transitional areas", from the normal, through dysplastic to neoplastic infiltrating squamous epithelium. These features suggest that this neoplasia originated from a dermoid cyst and make the hypothesis of a "collision tumor" less probable.
In our view, it is important to perform a differential diagnosis for an immature teratoma, since Blaustein (1994) hypothesised that on a dermoid cyst "invariably only one tissue element becomes malignant, and the presence of many different malignant elements indicates that the tumor is an immature teratoma and not a mature teratoma that has undergone malignant transformation" [13].
However, an immature malignant teratoma contains elements derived from all three germ layers and, shows a variety of lines of mesenchymal differentiation, notably towards neural elements. Finally it occurs in a younger (pre-menopausal) age group and it is almost never found in women older than 50 years [3, 14].
Furthermore, in our opinion, "carcinosarcoma" is the best term for this neoplasia because no immunoreactivity for keratin was detected in the sarcomatous component. On the other hand, "carcinosarcomas and sarcomatoid carcinomas are considered manifestations of the same biologic phenomenon by which the neoplastic cells lose in part or completely their epithelial markers and acquire mesenchymal ones" [15]. This consideration arises from the monoclonal histogenetic theory that is most widely accepted today for the majority of carcinosarcomas [16]. So in accordance with Arora and Haldane [4], we think our case of "carcinosarcoma arising in a dermoid cyst" derives from neoplastic totipotent stem cells with a probabilistic commitment of individual cells and clones to one or other expressed phenotype.
In our case we observed a positive stain for vimentin, alpha smooth muscle actin and CD10 not only in the sarcomatous component, but also in some atypical basal cells of the squamous epithelium.
The aberrant expression of these markers, unusual in normal squamous basal cells, suggests that they represent totipotent stem cells that are capable of commitment towards both epithelial and mesenchymal differentiation (Figure 2), and is difficult to reconcile with the hypothesis that they originate from the proliferation of two distinct clones, committed respectively to epithelial and connective differentiation.
Moreover, like Mayall et al. [15], we found concordant positive staining for p53 and p63 in both the epithelial and sarcomatous components, and, notably in our view, in the atypical basal cells of the squamous lining.
We think this case is interesting beceuse a carcinosarcoma-sarcomatoid carcinoma rarely arises from a dermoid cyst and because, to our knowledge, this is the first literature report of immunohistochemical findings that support the hypothesis that a carcinosarcoma can arise from neoplastic totipotent stem cells located in the basal layer of the squamous epithelium.
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://​creativecommons.​org/​licenses/​by/​2.​0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interest

The author(s) declare that they have not competing interests.

Authors' contributions

DC designed the study and drafted the manuscript.
AM collected the specimens and carried out the immunohistochemistry.
FC participated in the draft of the manuscript.
EB participated in the examination of the immunohistochemistry.
CDG participated in the collection of specimens.
VR participated in the design of the study and in the draft of the manuscript
Anhänge

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.
Literatur
1.
Zurück zum Zitat Pantoja E, Rodriguez-Ibanez I, Axtmayer RW, Noy MA, Pelegrina I: Complications of dermoid tumors of the ovary. Obstet Gynecol. 1975, 45: 89-94.PubMed Pantoja E, Rodriguez-Ibanez I, Axtmayer RW, Noy MA, Pelegrina I: Complications of dermoid tumors of the ovary. Obstet Gynecol. 1975, 45: 89-94.PubMed
2.
Zurück zum Zitat Russel P, Bannatyne P: Surgical pathology of the ovaries. Churchill Livingstone. 1989, : 436-440. Russel P, Bannatyne P: Surgical pathology of the ovaries. Churchill Livingstone. 1989, : 436-440.
3.
Zurück zum Zitat Rosai J: Female reproductive system. Ackerman's: Surgical pathology. Edited by: Mosby. 1996, Missouri, 2: 1319-1564. Eight Rosai J: Female reproductive system. Ackerman's: Surgical pathology. Edited by: Mosby. 1996, Missouri, 2: 1319-1564. Eight
5.
Zurück zum Zitat Hanada M, Tsujimura T, Shimizu H: Multiple malignancies (squamous cell carcinoma and sarcoma) arising in a dermoid cyst of the ovary. Acta pathol Jpn. 1981, 31: 681-688.PubMed Hanada M, Tsujimura T, Shimizu H: Multiple malignancies (squamous cell carcinoma and sarcoma) arising in a dermoid cyst of the ovary. Acta pathol Jpn. 1981, 31: 681-688.PubMed
6.
Zurück zum Zitat Tyagi SP, Maheshwari V, Tyagi N, Tewari K: Double malignancy in a benign cystic teratoma of the ovary. Indian J Cancer. 1993, 30: 140-143.PubMed Tyagi SP, Maheshwari V, Tyagi N, Tewari K: Double malignancy in a benign cystic teratoma of the ovary. Indian J Cancer. 1993, 30: 140-143.PubMed
7.
Zurück zum Zitat Pathak S: Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 2002, 22: 1353-1356.PubMed Pathak S: Organ- and tissue-specific stem cells and carcinogenesis. Anticancer Res. 2002, 22: 1353-1356.PubMed
8.
Zurück zum Zitat Pomara G, Cappello F, Cuttano MG, Rappa F, Morelli G, Mancini P, Selli C: Primitive Neuroectodermal Tumor (PNET) of the kidney: a case report. BMC Cancer. 2004, 4: 3-. 10.1186/1471-2407-4-3.CrossRefPubMedPubMedCentral Pomara G, Cappello F, Cuttano MG, Rappa F, Morelli G, Mancini P, Selli C: Primitive Neuroectodermal Tumor (PNET) of the kidney: a case report. BMC Cancer. 2004, 4: 3-. 10.1186/1471-2407-4-3.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Sell S, Pierce GB: Maturation arrest of stem cell differentiation in a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994, 70: 6-22.PubMed Sell S, Pierce GB: Maturation arrest of stem cell differentiation in a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994, 70: 6-22.PubMed
10.
Zurück zum Zitat Thompson L, Chang B, Barsky SH: Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996, 20: 277-285. 10.1097/00000478-199603000-00003.CrossRefPubMed Thompson L, Chang B, Barsky SH: Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis. Am J Surg Pathol. 1996, 20: 277-285. 10.1097/00000478-199603000-00003.CrossRefPubMed
11.
Zurück zum Zitat Mayall F, Rutty K, Campbell F, Goddard H: P53 immunostaining suggest that the uterine carcinosarcomas are monoclonal. Histopathology. 1994, 24: 211-214.CrossRefPubMed Mayall F, Rutty K, Campbell F, Goddard H: P53 immunostaining suggest that the uterine carcinosarcomas are monoclonal. Histopathology. 1994, 24: 211-214.CrossRefPubMed
12.
Zurück zum Zitat Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncologic Group pathologic study of 203 cases. Int J Gynecol Pathol. 1990, 9: 1-19.CrossRefPubMed Silverberg SG, Major FJ, Blessing JA, Fetter B, Askin FB, Liao SY, Miller A: Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecologic Oncologic Group pathologic study of 203 cases. Int J Gynecol Pathol. 1990, 9: 1-19.CrossRefPubMed
13.
Zurück zum Zitat Kurman RJ: Surface epithelial-stromal tumors of the ovary. Balustein's: Pathology of the femal genital tract. Edited by: Springer-Verlag. 1994, New-York, 749-750. FourtCrossRef Kurman RJ: Surface epithelial-stromal tumors of the ovary. Balustein's: Pathology of the femal genital tract. Edited by: Springer-Verlag. 1994, New-York, 749-750. FourtCrossRef
14.
Zurück zum Zitat Mills SE, Carter D, Greenson J, Oberman HA, Reuter V, Stoler MH: Ovarian surface epithelial stromal tumors. Sternberg's Diagnostic Surgical Pathology. 2004, Lippincott Williamsm, Wilkins, 2: 2542-2578. 4 Mills SE, Carter D, Greenson J, Oberman HA, Reuter V, Stoler MH: Ovarian surface epithelial stromal tumors. Sternberg's Diagnostic Surgical Pathology. 2004, Lippincott Williamsm, Wilkins, 2: 2542-2578. 4
15.
Zurück zum Zitat Rosai J: Respiratory tract. Ackerman's: Surgical pathology. 2004, : 305-458. Rosai J: Respiratory tract. Ackerman's: Surgical pathology. 2004, : 305-458.
16.
Zurück zum Zitat WG McCluggage: Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol. 2002, 55: 321-325.CrossRef WG McCluggage: Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol. 2002, 55: 321-325.CrossRef
Metadaten
Titel
Carcinosarcoma of monoclonal origin arising in a dermoid cyst of ovary: a case report
verfasst von
Daniela Cabibi
Anna Martorana
Francesco Cappello
Elisa Barresi
Claudio Di Gangi
Vito Rodolico
Publikationsdatum
01.12.2006
Verlag
BioMed Central
Erschienen in
BMC Cancer / Ausgabe 1/2006
Elektronische ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-47

Weitere Artikel der Ausgabe 1/2006

BMC Cancer 1/2006 Zur Ausgabe

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Brustkrebs-Prävention wird neu gedacht

04.06.2024 ASCO 2024 Kongressbericht

Zurzeit untersuchen Forschende verschiedene neue Ansätze zur Prävention von Brustkrebs bei Personen mit hohem Risiko. Darunter Denosumab, die prophylaktische Bestrahlung der Brust – und Impfungen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.